ArticleJournal of animal science2025
Folic acid supplementation alleviates donor cattle's heat stress and improves in vitro embryo production efficiency in summer.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To mitigate the detrimental effects of heat stress (HS) on the production efficiency of Wagyu cattle oocyte pick-up (OPU)-in vitro fertilization (IVF), this study conducted a 20-d folic acid (VB9) supplementation trial in Wagyu cattle under HS conditions. Using a staged repeated measurements design, OPU-IVF production procedures were performed on Wagyu cattle (12-mo-old, n = 5 out of 20 total) at six time points during the supplementation period (days 0, 4, 8, 12, 16, and 20). ELISA-based biochemical assays were employed to evaluate the effects of VB9 supplementation on HS-related indicators in serum and follicular fluid of Wagyu cattle under HS conditions. Untargeted metabolomics was further utilized to analyze the impact of VB9 on metabolic profiles in the follicular fluid. The results demonstrated that supplementation with VB9 for 20 d significantly improved both oocyte quality and developmental competence obtained via OPU (n = 5), markedly enhancing cleavage rate (58.14% vs. 24.08%; P < 0.05) and blastocyst rate (35.9% vs. 10.58%; P < 0.05). VB9 supplementation significantly reduced HS-related indicators in both serum and follicular fluid, including levels of heat shock protein 70 (HSP70), heat shock protein 90 (HSP90), interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), malondialdehyde (MDA), and reactive oxygen species (ROS). Concurrently, total antioxidant capacity (T-AOC) was significantly increased, and the activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-PX) were markedly elevated. Estradiol (E2) and progesterone (P4) levels were significantly increased, while the P4-to-E2 ratio exhibited a significant decrease. Furthermore, untargeted metabolomic analysis revealed 1,557 differentially expressed metabolites (DEMs) in follicular fluid following VB9 supplementation. These DEMs were primarily enriched in metabolic pathways, including purine metabolism, phenylalanine and tyrosine metabolism, steroid hormone biosynthesis, and ABC transporters. In conclusion, VB9 supplementation enhances OPU-IVF production efficiency under HS conditions and offers novel insights into the molecular mechanisms underlying VB9-mediated HS mitigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.